Re-engineering of the Duocarmycin Structural Architecture Enables Bioprecursor Development Targeting CYP1A1 and CYP2W1 for Biological Activity

Helen M. Sheldrake, Sandra Travica, Inger Johansson, Paul M. Loadman, Mark Sutherland, Lina Elsalem, Nicola Illingworth, Alexander J. Cresswell, Tristan Reuillon, Steven D. Shnyder, Souren Mkrtchian, Mark Searcey, Magnus Ingelman-Sundberg, Laurence H. Patterson, Klaus Pors

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)
Original languageEnglish
Pages (from-to)6273-6277
Number of pages5
JournalJournal of Medicinal Chemistry
Issue number15
Publication statusPublished - 11 Jul 2013

Cite this